#jn1variant
JN.1 COVID Variant in India: Symptoms & Prevention Tips
India is witnessing a fresh surge in COVID-19 cases, primarily driven by a new variant identified as JN.1. According to the Union Health Ministry, 257 active COVID cases have been recorded across states, with the majority arising in Maharashtra, Kerala, and Tamil Nadu. This variant is believed to have originated in Southeast Asia and is now spreading in parts of India, echoing similar spikes seen in Singapore, Hong Kong, and Thailand. What is the JN.1 Variant?
JN.1 COVID Variant in India: Symptoms & Prevention Tips
India is witnessing a fresh surge in COVID-19 cases, primarily driven by a new variant identified as JN.1. According to the Union Health Ministry, 257 active COVID cases have been recorded across states, with the majority arising in Maharashtra, Kerala, and Tamil Nadu. This variant is believed to have originated in Southeast Asia and is now spreading in parts of India, echoing similar spikes seen in Singapore, Hong Kong, and Thailand. What is the JN.1 Variant?
Nasal COVID Vaccine Could Replace Booster Shots
As COVID-19 cases begin rising once again across several Asian nations, health authorities and researchers are looking into alternative forms of protection especially for people hesitant to take another jab. The recent increase in infections has been particularly notable in Hong Kong, Singapore, Thailand, and India, with India reporting 257 active cases as of May 19, according to the Union Health Ministry. The surge coincides with the global spread of the JN.1 variant, a sublineage
Nasal COVID Vaccine Could Replace Booster Shots
As COVID-19 cases begin rising once again across several Asian nations, health authorities and researchers are looking into alternative forms of protection especially for people hesitant to take another jab. The recent increase in infections has been particularly notable in Hong Kong, Singapore, Thailand, and India, with India reporting 257 active cases as of May 19, according to the Union Health Ministry. The surge coincides with the global spread of the JN.1 variant, a sublineage









